![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1334614
¼¼°èÀÇ ¿åâ ¿¹¹æ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2023-2030³â)Global Pressure Ulcer Prevention Market Size Study & Forecast, by Product Type, By End-User, and Regional Analysis, 2023-2030 |
¼¼°è ¿åâ ¿¹¹æ ½ÃÀåÀº 2022³â ¾à 10¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â¿¡´Â 4.0% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿åâÀº ¿åâÀ̶ó°íµµ Çϸç, ÇǺο¡ Àå½Ã°£ ¾Ð·ÂÀÌ °¡ÇØÁ® ÇǺΰ¡ ¼Õ»óµÈ ºÎÀ§¸¦ ¸»ÇÕ´Ï´Ù. ¿åâÀº ½Åü ¾î´À ºÎÀ§¿¡¼³ª ¹ß»ýÇÒ ¼ö ÀÖÁö¸¸ ¾ûµ¢ÀÌ, ÆÈ²ÞÄ¡, ¹ßµÚ²ÞÄ¡, ¾î±ú µî ºÎÀ§¿¡ °¡Àå ¸¹ÀÌ ¹ß»ýÇÕ´Ï´Ù. ¿åâÀº ½É°¢ÇÑ ¹®Á¦À̸ç, °¨¿°°ú ÆÐÇ÷ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ°í, °æ¿ì¿¡ µû¶ó¼´Â »ç¸Á¿¡ À̸¦ ¼öµµ ÀÖ½À´Ï´Ù. ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, »óóÀÇ Á¶±â ȸº¹¿¡ ´ëÇÑ °ü½É Áõ°¡, ÀÔ¿ø ȯÀÚÀÇ ¿åâ ±ÞÁõ, »õ·Î¿î ¿åâ ¿¹¹æ Á¦Ç°ÀÇ °³¹ß Áõ°¡´Â Àü ¼¼°èÀûÀ¸·Î ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.
¶ÇÇÑ °í·ÉÈ·Î ÀÎÇØ COPD, ´ç´¢º´, ½ÅºÎÀü µî ¸¸¼ºÁúȯ¿¡ °É¸®±â ½±½À´Ï´Ù. ±× °á°ú ÀÔ¿ø ±â°£ÀÌ ±æ¾îÁö°í ³ëÀÎÀÇ Ã¼¾Ð »óÇØ°¡ ¹ß»ýÇÕ´Ï´Ù. µû¶ó¼ ³ëÀÎ Àα¸ÀÇ Áõ°¡´Â ¼¼°è ½ÃÀå ¹ßÀü¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ º¸°í¼¿¡ µû¸£¸é ³ëÀÎ Àα¸´Â 2020³â 10¾ï ¸í¿¡¼ 2030³â 15¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, Àü ¼¼°è 60¼¼ ÀÌ»ó Àα¸ 6¸í Áß 1¸íÀÌ ³ëÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µû¶ó¼ ºü¸£°Ô Áõ°¡ÇÏ´Â ³ëÀÎ Àα¸´Â ´Ù¾çÇÑ Áúº´¿¡ °É¸®±â ½¬¿ö ½ÃÀå ¼ºÀåÀÇ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿åâ ¿¹¹æ¿¡ ÀÖ¾î ÷´Ü ±â¼úÀÇ È°¿ëÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ¿åâ ¿¹¹æÀ» À§ÇÑ Á¤ºÎÀÇ ³ë·ÂÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ¿¹Ãø ±â°£ µ¿¾È ´Ù¾çÇÑ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¿åâ ¿¹¹æ°ú °ü·ÃµÈ ³ôÀº ºñ¿ë°ú ¿åâ ¿¹¹æÀÇ º¹À⼺Àº 2023³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
¿åâ ¿¹¹æ ¼¼°è ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ Àνİú Á߿伺ÀÌ ³ô¾ÆÁö°í ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ ±â¼ú ¹× Á¦Ç° Çõ½ÅÀÌ Áõ°¡ÇÔ¿¡ µû¶ó 2022³â ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó °³¹ß, °í·ÉÈ Àα¸ÀÇ Áõ°¡, Àå±â ¿ä¾ç ½Ã¼³ÀÇ Áõ°¡ µîÀÌ ÀÌ Áö¿ª Àüü ½ÃÀå ¼ö¿ä¸¦ Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå °¡Ä¡¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.
Global Pressure Ulcer Prevention Market is valued at approximately USD 1.04 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4.0% over the forecast period 2023-2030. Pressure ulcers, also known as bedsores, are areas of damaged skin that develop when pressure is applied to the skin for a long period of time. Pressure ulcers occur anywhere on the body, but they are most common in parts such as the hips, elbows, heels, and shoulders. Pressure ulcers are considered a serious problem and they may result in infection, sepsis, and in a few cases death. The increasing prevalence of chronic diseases, growing focus on the faster recovery of wounds, surge in the prevalence of pressure ulcers in hospital inpatient settings, and rising development of new pressure ulcer prevention products are the key factors that are propelling the market growth across the globe.
Additionally, the aging population is more vulnerable to chronic diseases like COPD, diabetes, and renal failure. This leads to prolonged hospitalization, which results in pressure injuries in the elderly population. Accordingly, the increasing geriatric population is exhibiting a positive influence on the market development globally. The World Health Organization (WHO) reported that it is anticipated that the number of aging people increase from 1 billion in 2020 to 1.5 billion in 2030 which worldwide accounts for 1 in 6 people above 60. Hence, the rapidly growing geriatric population is more prone to be affected by a range of diseases, which is creating lucrative opportunities for market growth. Furthermore, the surging use of advanced technologies in the prevention of pressure ulcers, as well as the increasing government initiatives to promote pressure ulcer prevention present various lucrative opportunities over the forecasting years. However, the high costs associated with pressure ulcer prevention and the complexity of pressure ulcer prevention are hampering the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Pressure Ulcer Prevention Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing awareness and emphasis on patient safety, as well as increasing advancements in technology and product innovation by the key market players Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The increasing government initiatives, development of the healthcare infrastructure, as well as rising aging population and long-term care facilities are significantly propelling the market demand across the region.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.